Yttrium-90 Chelation Properties of Tetraazatetraacetic Acid Macrocycles, Diethylenetriaminepentaacetic Acid Analogs, and a Novel Terpyridine Acyclic Chelator

Bioconjugate Chemistry

Volumn 6, Issue 2, 1995, Pages 219-225

  Stimmel, Julie B ^a   Stockstill, Marie E ^a   Kull, Frederick C ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; AMINE; CHELATING AGENT; PENTETIC ACID; TRACE ELEMENT; YTTRIUM;

ARTICLE; CHEMISTRY; ISOTOPE LABELING; KINETICS; PH;

ACETIC ACIDS; AMINES; CHELATING AGENTS; HYDROGEN-ION CONCENTRATION; ISOTOPE LABELING; KINETICS; PENTETIC ACID; TRACE ELEMENTS; YTTRIUM; YTTRIUM RADIOISOTOPES;

EID: 0029261677     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc00032a010     Document Type: Article

References (43)

1. Grossbard, M. L., Press, O. W., Appelbaum, F. R., Bernstein, I. D., and Nadler, L. M. (1992) Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 80, 863-878.
2. Hnatowich, D. J., Virzi, F., and Doherty, P. W. (1985) DTPA-coupled antibodies labeled with yttrium-90. J. Nucl. Med. 26, 503-509.
3. Larson, S. M., Carrasquillo, J. A., Reynolds, J. C., Hellstrom, I., Hellstrom, K. E., Mulshine, J. C., and Mattis, L. E. (1986) Therapeutic applications of radiolabeled antibodies: current situation and prospects. Nucl. Med. Biol. 13, 207-213.
4. Anderson-Berg, W. T., Squire, R. A., and Strand, M. (1987) Specific radioimmunotherapy using 90Y-labeled monoclonal antibody in erythroleukemic mice. Cancer Res. 47, 1905-1912.
5. Hnatowich, D. J., Chinol, M., Siebecker, D. A., Gionet, M., Griffin, T., Doherty, P. W., Hunter, R., and Kase, K. R. (1988) Patient biodistribution of intraperitoneally administered yttrium-90-labeled antibody. J. Nucl. Med. 29, 1428-1435.
6. Sharkey, R. M., Kaltovich, F. A., Shih, L. B., Fand, I., Govelitz, G., and Goldenberg, D. M. (1988) Radioimmunotherapy of human colonic cancer xenografts with 90Y-labeled monoclonal antibodies to carcinoembryonic antigen. Cancer Res. 48, 3270-3275.
7. Stewart, J. S. W., Hird, V., Snook, D., Sullivan, M., Myers, M. J., and Epenetos, A. A. (1988) Intraperitoneal 1311-and 90Y-labelled monoclonal antibodies for ovarian cancer: pharmacokinetics and normal tissue dosimetry. Int. J. Cancer 42(Supplement. 3), 71-76.
8. Rowlinson, G., Snook, D., Stewart, S., and Epenetos, A. A. (1989) Intravenous EDTA to reduce uptake following 90Y-labelled monoclonal antibody administration. Br. J. Cancer 59, 322.
9. Hird, V., Stewart, J. S., Snook, D., Dhokia, B., Coulter, C., Lambert, H. E., Mason, W. P., Soutier, W. P., and Epenetos, A. A. (1990) Intraperitoneally administered 90Y-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions. Br. J. Cancer Suppl. 10, 48-51.
10. Rosenblum, M. G., Kavanagh, J. J., Burke, T. W., Wharton, J. T., Cunningham, J. E., et al. (1991) Clinical pharmacology, metabolism and tissue distribution of 90Y-labeled monoclonal antibody B72. 3 after intraperitoneal administration. J. Natl. Can. Inst. 83 (22), 1629-1636.
11. Haller, D., Cannon, L., Alavi, A., and Gulfo, J. (1992) A Phase I Trial of 90Y labeled monoclonal antibody (MoAb) B72. 3 [CYT-103-90Y] administration with concurrent EDTA in refractory adenocarcinoma. Antibody, Immunoconjugates, Radiopharm. 5, Abstr. 100, 147.
12. Kozak, R. W., Raubitschek, A., Mirzadeh, S., Brechbiel, M. W., Junghaus, R., Gansow, O. A., and Waldmann, T. A. (1989) Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity. Cancer Res. 49, 2639-2644.
13. Brechbiel, M. W., and Gansow, O. A. (1991) Backbone-substituted DTPA ligands for 90Y radioimmunotherapy. Bioconjugate Chem. 2, 187-194.
14. Brechbiel, M. W., and Gansow, O. A. (1992) Synthesis of C-functionalized irarcs-cyclohexyldiethylenetriaminepenta-acetic acids for labeling of monoclonal antibodies with the bismuth-212 a-particle emitter. J. Chem. Soc., Perkin Trans. 1 1175-1178.
15. Camera, L., Kinuya, S., Pai, L. H., Garmestani, K., Brechbiel, M. W., Gansow, O. A., Paik, C. H., Pastan, I., and Carrasquillo, J. A. (1993) Preclinical evaluation of mIn-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epedermoid carcinoma xenografts. Cancer Res. 53, 2834-2839.
16. Toner, J. L. (1989) Terpyridine Chelating Agents. U. S. Patent No. 4, 859, 777.
17. Moi, M. K. Meares, C. F., and DeNardo, S. J. (1988) The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(ϱ-nitrobenzyl)-1, 4, 7, 10-tetraazacyclotridecane-Ar, N', N, N”, N”-tetraacetic acid and study of its yttrium(III) complex. J. Am. Chem. Soc. 110, 6267-6269.
18. Deshpande, S. V., DeNardo, S. J., Kukis, D. L., Moi, M. K., McCall, M. J., DeNardo, G. L., and Meares, C. F. (1990) Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. J. Nucl. Med. 31, 473-479.
19. Desreux, J. F. (1980) Nuclear magnetic resonance spectroscopy of lanthanide complexes with a tetraacetic tetraaza macrocycle. Unusual conformation properties. Inorg. Chem. 19, 1319-1324.
20. Brechbiel, M. W., Wu, C., McMurry, T. J., Gansow, O. A., Garmestani, K., et al. (1993) Synthesis and evaluation of 2-(Q-SCN-benzyl)-trans-cyclohexyl-DTPA's for radioimmunoim-aging and radioimmunotherapy with mIn and 90Y. Antibody, Immunoconjugates, Radiopharm. 6, Abstr. 47, 78.
21. Mirzadeh, S., Brechbiel, M. W., Atcher, R. W., and Gansow, O. A. (1990) Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl) diethylenetriaminepentaacetic acid ligands to immunoglobulin. Bioconjugate Chem. 1, 59-65.
22. Harrison, A., Walker, C. A., Parker, D., Jankowski, K. J., Cox, J. P., et al. (1991) The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates. Nucl. Med. Biol. 18 (5), 469-476.
23. Broan, C. J., Cox, J. P. L., Craig, A. S., et al. (1991) Structure and solution stability of indium and gallium complexes of 1, 4, 7-triazacyclononanetriacetate and of yttrium complexes of 1, 4, 7, 10-tetraazacyclododecanetetraacetate and related ligands: kinetically stable complexes for use in imaging and radioimmunotherapy. X-Ray molecular structure of the indium and gallium complexes of 1, 4, 7-triazacyclononane-1, 4, 7-triacetic acid. J. Chem. Soc., Perkin Trans. 2 87-98.
24. Kroger, L. A., DeNardo, G. L., DeNardo, S. J., Miers, L. A., and Meares, C. F. (1992) Comparative toxicity studies of a yttrium-90 labeled MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Antibody, Immunoconjugates, Radiopharm. 5, Abstr. 94, 357.
25. Kruper, W. J., Jr. (1991) Process for preparing mono-N-alkylated polyazamacrocycles. U. S. Patent No. 5, 064, 956.
26. Schlom, J., Siler, K. Milenic, D. E., Eggensperger, D., Colcher, D., et al. (1991) Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate. Cancer Res. 51, 2889-2896.
27. Schott, M. E., Milenic, D. E., Yokota, T., Whitlow, M., Wood, J. F., Fordyce, W. A., Cheng, R. C., and Schlom, J. (1992) Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules. Cancer Res. 52, 6413-6417.
28. Schlom, J., Siler, K., Milenic, D. E., Eggensperger, D., Colcher, D., et al. (1992) Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates. Antibodies, Immunoconjugates, Radiopharm. 5, Abstr. 42, 340.
29. Ruser, G., Ritter, W., and Maecke, H. R. (1990) Synthesis and evaluation of two bifunctional carboxymethylated tet-raazamacrocyclic chelating agents for protein labeling with indium-111. Bioconjugate Chem. 1, 345-349.
30. Thiers, R. E. (1957) Contamination in trace element analysis and its control. Methods Biochem. Anal. 5, 273-335.
31. Meares, C. F., McCall, M. J., Reardan, D. T., Goodwin, D. A., Diamanti, C. I., and McTigue, M. (1984) Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents: methods of analysis, and subsequent addition of metal ions. Anal. Biochem. 142, 68-78.
32. Kukis, D. L., Li, M., and Meares, C. F. (1993) Selectively of antibody-chelate conjugates for binding copper in the presence of competing metals, lnorg. Chem. 32, 3981-3982.
33. Cummins, C. H., Rutter, E. W., and Fordyce, W. A. (1991) A convenient synthesis of bifunctional chelating agents based on diethylenetriaminepentaacetic acid and their coordination chemistry with yttrium (III). Bioconjugate Chem. 2, 180-186.
34. Camera, L., Kinuya, S., Garmestani, K, Wu, C., Brechbiel, M. W., et al. (1994) Evaluation of serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies. J. Nucl. Med. 35, 882889.
35. DeNardo, G. L., Koger, L. A., DeNardo, S. J., Miers, L. A., Salako, Q., et al. (1994) Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Cancer (Supplment) 733, 1012-1022.
36. Tse, P. K., and Powell, J. E. (1985) Study of structural influence on the formation constants of lanthanide-polyamino polycarboxylate complexes, lnorg. Chem. 24, 2727-2730.
37. Cacheris, W. P., Nickle, S. K., and Sherry, A. D. (1987) Thermodynamic study of lanthanide complexes of 1, 4, 7-triazacyclononane-N, N', N”-triacetic acid and 1, 4, 7, 10-tetraazacyclododecane-N, N', N”, N”'-tetraacetic acid. lnorg. Chem. 26, 958-960.
38. Nyssen, G. A., and Margerum, D. W. (1970) Multidentate ligand kinetics. XIV. Formation and dissociation kinetics of rare earth-cyclohexylenediaminetetraacetate complexes. In-org. Chem. 9, 1814-1820.
39. De Jonghe, M., and D'Olieslager, W. (1985) The dissociation kinetics of rare earths-N-methylethylenediamine-N, N', N'-triacetate complexes. lnorg. Chim. Acta 109, 7-14.
40. Ascenso, J. R., Delgado, R., and Frausto da Silva, J. J. R. Nuclear magnetic resonance studies of the protonation sequence of cyclic tetra-azatetraacetic acids. J. Chem. Soc., Perkin Trans. 2, 781-788.
41. Loncin, M. F., Desreux, J. F., and Merciny, E. (1986) Coordination of lanthanides by two polyamino polycarboxylic macrocycles: formation of highly stable lanthanide complexes. lnorg. Chem. 25, 2646-2648.
42. Clarke, E. T., Martell, A. E. (1991) Stabilities of the alkaline earth and divalent transition methal complexes of the tetraazamacrocyclic tetraacetic acid ligands. lnorg. Chim. Acta 190, 27-36.
43. Clarke, E. T., and Martell, A. E. (1991) Stabilities of trivalent metal ion complexes of the tetraacetate derivatives of 12-, 13-, and 14-membered tetraazamacrocycles. lnorg. Chim. Acta 190, 37-46.